Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company NanoBio Corp.
DescriptionIntranasal nanoemulsion containing recombinant hepatitis B surface antigen (HBsAg)
Molecular Target Hepatitis B surface antigen (HBsAg)
Mechanism of ActionVaccine
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationHepatitis B virus (HBV)
Indication DetailsTreat and prevent hepatitis B virus (HBV) infection
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today